RHP 5.54MTRN 4.28PSMT 0ESLOY 0MSFT -10.75META -5.94HLPR.TO 0.02VDY.TO 0.5
Teva Pharmaceutical (TEVA)
The ultimate 360° Tracker Your financial life in one place, automatically

NYSE:TEVA

Teva Pharmaceutical (TEVA)

34.22
+1.01 (3.04%)
as of Jun 24, 2026, 8:00:00 pm Market Open.
69 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
Investor Insights
star iconJun 24, 2026, 12:00 am

This summary was created by AI, based on 3 opinions in the last 12 months.

Teva Pharmaceutical, represented by the symbol TEVA-N, is currently experiencing a robust demand for GLP (glucose-lowering agents), although the entry of more generics may lead to price declines in this sector. The company has shown a remarkable recovery under its current CEO, boasting a 264% increase since January 2023, suggesting it's on a promising turnaround. Its headquarters are located in Israel, and it holds a strong position as a large-cap pharmaceutical company, ranking #1 in its ADR/CDR universe among international stocks. Following a breakout over $21 in September, Teva has seen significant accumulation over the past six months, although it does not pay dividends. Analysts remain optimistic, with a price target of $34.50.

consensus icon
Consensus
positive
valuation icon
Valuation
undervalued
review icon
Similar
Roche, RHHBY
DON'T BUY

Teva Pharmaceutical(TEVA)

Oct 05, 2004
Prefers others.
Photo of Don ReedDon Reed
No
Unlock Rating
$25.67

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
BUY

Teva Pharmaceutical(TEVA)

Aug 27, 2004
One of the world's largest genetic drug manufactor company. The stock has dropped in the last few weeks. This is a good opportunity to buy stocks.
Photo of Norman LevineNorman LevineUnlock Rating
$28.39

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Teva Pharmaceutical(TEVA)

Jun 04, 2004
Wonderful company. Not overvalued.
Photo of Lou HollandLou Holland
Owned
Unlock Rating
$65.08

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
BUY ON WEAKNESS

Teva Pharmaceutical(TEVA)

Jul 17, 2003
Generic drugs is a great sector. This one is the leader. Accumulate on a gradual basis.
Photo of Brad WillockBrad WillockUnlock Rating
$55.96

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
HOLD

Teva Pharmaceutical(TEVA)

Jun 24, 2003
Generic drug space is a good place to be. A little high now.
Photo of Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. Sc
Owned
Unlock Rating
$54.60

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Teva Pharmaceutical(TEVA)

Apr 01, 2003
Generic drugs have done very well. Have increased their margins regularily. Steadily moving up.
Photo of David BurrowsDavid BurrowsUnlock Rating
$43.60

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
BUY

Teva Pharmaceutical(TEVA)

Jan 13, 2003
Good growth trend. Good products. May drop in the near term.
Photo of David BurrowsDavid BurrowsUnlock Rating
$37.90

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Teva Pharmaceutical(TEVA)

Dec 16, 2002
Likes the generic drug sector.
Photo of David BurrowsDavid BurrowsUnlock Rating
$38.88

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Teva Pharmaceutical(TEVA)

Sep 24, 2002
(Was a top pick on Aug 23. Up 1%) Still likes. Likess the generic sector in drugs.
Photo of David BurrowsDavid BurrowsUnlock Rating
$67.87

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Teva Pharmaceutical(TEVA)

Aug 23, 2002
Stable revenue stream and earnings record. Likes the generic drug sector.
Photo of David BurrowsDavid BurrowsUnlock Rating
$66.90

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Teva Pharmaceutical(TEVA)

Aug 21, 2002
(Was a top pick on Mar 15. Up 19%.) Still likes.
Photo of Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. ScUnlock Rating
$67.72

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Teva Pharmaceutical(TEVA)

Aug 16, 2002
(Was a top pick on June 21. Up 7.1%) Good long term story.
Photo of Brad WillockBrad WillockUnlock Rating
$68.39

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Teva Pharmaceutical(TEVA)

Apr 19, 2002
Over 50 new drugs waiting approval. Cheap.
Photo of Brad WillockBrad WillockUnlock Rating
$57.38

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Teva Pharmaceutical(TEVA)

Apr 05, 2002
Global. Good acquisitions. Because it is based in Israel, price has dropped inordinately.
Photo of Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. ScUnlock Rating
$55.10

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Teva Pharmaceutical(TEVA)

Mar 15, 2002
World leader in generic drugs.
Photo of Jonathen Wellum, B. Comm, B. ScJonathen Wellum, B. Comm, B. ScUnlock Rating
$57.16

Stock price when the opinion was issued

$34.17

As of Jun 25, 2026. Market Open.

biotechnologypharmaceutical
Showing 256 to 270 of 275 entries

You may also like

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

MSFT -10.75$354.71
PPL.TO 0.3$66.45
CVE.TO -0.02$35.07
TOU.TO 0.125$59.985
GOOG -4.4$340.64

Today's Top Picks

RHP 5.54$129.77
MTRN 4.28$269.62
PSMT 0$
ESLOY 0$95.66
MSFT -10.75$354.71

Popular Articles

Latest Sell Signals

ATD.TO 0.39$94.15
ITB 2.5$105.82
GLD 2.65$368.57
MU 142.14$1190.65
MU 142.14$1190.65

Most Recent Experts

Brendan Caldwell

Brendan Caldwell

Caldwell Securities

Liz Young, Head of investment strategy at SoFi

Liz Young, Head of investment strategy at SoFi

SoFi

Stephen Weiss, Founder, Short Hills Capital Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Joe Terranova

Joe Terranova

Virtus Investment Partners

Paul Harris, CFA

Paul Harris, CFA

Harris Douglas Asset Management

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica